Indian Cambrex Plant Receives EU GMP Approval

12:26 PM MST | January 18, 2011 | Vincent Valk

Cambrex's manufacturing facility at Hyderabad, India has received good manufacturing practice (GMP) approval from Danish authorities, allowing the company to speed the export of products made at the site to Europe. The site produces nicotine replacement therapy lozenges and chewing gums, and other pharmaceutical products. The Danish GMP approval certificate is recognized by other EU countries, as well, Cambrex says. "This commercially important and significant milestone for Cambrex confirms our commitment to quality in every aspect of operations management...